Short Interest in Sunshine Biopharma, Inc. (NASDAQ:SBFM) Rises By 16.4%

Sunshine Biopharma, Inc. (NASDAQ:SBFM) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 374,100 shares, a growth of 16.4% from the October 15th total of 321,500 shares. Approximately 18.7% of the shares of the company are short sold. Based on an average daily volume of 180,600 shares, the days-to-cover ratio is currently 2.1 days.

Sunshine Biopharma Stock Performance

SBFM stock traded down $0.22 during trading on Friday, reaching $2.35. The company had a trading volume of 311,442 shares, compared to its average volume of 128,355. The company has a market cap of $2.87 million, a price-to-earnings ratio of -0.02 and a beta of 1.38. Sunshine Biopharma has a twelve month low of $2.25 and a twelve month high of $637.20. The firm has a 50-day simple moving average of $2.92 and a 200-day simple moving average of $1.72.

Sunshine Biopharma (NASDAQ:SBFM) last posted its quarterly earnings data on Tuesday, November 5th. The company reported ($0.94) EPS for the quarter, missing the consensus estimate of $9.00 by ($9.94). The company had revenue of $8.44 million for the quarter. Sunshine Biopharma had a negative return on equity of 17.89% and a negative net margin of 12.82%.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.